Laura Orio Ortíz

Title: Laura Orio Ortíz: Innovator in GLP-1 Modulation

Introduction

Laura Orio Ortíz is a prominent inventor based in Málaga, Spain. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that modulate the GLP-1 peptide receptor. Her work is crucial in addressing various metabolic disorders.

Latest Patents

Laura holds a patent for "1,2,4-oxadiazole derivatives as drugs modulating the GLP-1 peptide receptor." This invention relates to the use of a compound of formula (I) or a pharmaceutically acceptable solvate or salt thereof in the preparation of a medicinal product. The patent focuses on the prevention and treatment of diseases where the GLP-1 receptor plays a role, such as obesity, anorexia, lipid dysfunction, diabetes, hyperinsulinism, cardiovascular diseases, and metabolic syndrome. She has 1 patent to her name.

Career Highlights

Laura is currently associated with Vivia Biotech S.L., where she continues her research and development efforts. Her innovative approach and dedication to her work have positioned her as a key figure in her field.

Collaborations

Throughout her career, Laura has collaborated with notable professionals, including Fernando Rodríguez De Fonseca and Miguel Romero Cuevas. These partnerships have enhanced her research and contributed to the advancement of her projects.

Conclusion

Laura Orio Ortíz is a trailblazer in the field of medicinal chemistry, with her work on GLP-1 modulation paving the way for new treatments for metabolic disorders. Her contributions are invaluable to the scientific community and the development of effective therapies.